Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY) / Aversa, Franco; Bacharlustig, E; Prezioso, L; Bonomini, S; Geva, No; Monti, A; Manfra, I; Schifano, C; Galaverna, F; Klionsky, Yz; Reisner, Y.. - In: BLOOD. - ISSN 0006-4971. - 128:(2016). ((Intervento presentato al convegno 58th Annual Meeting and Exposition of the American-Society-of-Hematology tenutosi a San Diego, CA nel Dec 2016.

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY)

AVERSA, Franco;
2016-01-01

Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY) / Aversa, Franco; Bacharlustig, E; Prezioso, L; Bonomini, S; Geva, No; Monti, A; Manfra, I; Schifano, C; Galaverna, F; Klionsky, Yz; Reisner, Y.. - In: BLOOD. - ISSN 0006-4971. - 128:(2016). ((Intervento presentato al convegno 58th Annual Meeting and Exposition of the American-Society-of-Hematology tenutosi a San Diego, CA nel Dec 2016.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2832741
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact